Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inflitza 25mg Capsule
Manufacturer/Marketed By : INTAS PHARMACEUTICALS LTD
$42.78 $34.23
Sidmex Inovia offers bulk export supply of Inflitza 25mg Capsule (MIDOSTAURIN) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
MIDOSTAURIN
Active Pharmaceutical Ingredient
Inflitza 25mg Capsule
$42.78
$34.23
Sidmex Inovia offers bulk export supply of Inflitza 25mg Capsule (MIDOSTAURIN) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: Philippines, United Arab Emirates, Kenya, Egypt, Brazil. We also export worldwide, including:
Middle East: United Arab Emirates, Saudi Arabia, Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Turkey
Africa: Egypt, Algeria, Morocco, Libya, Nigeria, Ghana, Benin, Burkina Faso, Côte d'Ivoire, Gambia, Kenya, Tanzania, Rwanda, Ethiopia, Djibouti, Somalia, South Africa, Zimbabwe, Mauritius
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Singapore, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia
Latin America & Caribbean: Mexico, Brazil, Chile, Peru, Colombia, Bolivia, Dominican Republic, Bahamas, Barbados
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Inflitza 25mg capsule contains the active substance midostaurin. It is an anti-cancer medicine belongs to the class of medications called tyrosine kinase inhibitors. It is combined with other chemotherapy medications to treat acute myeloid leukemia (AML) in adults with a defect in a gene called FLT3. Acute myeloid leukemia is a form of cancer that starts in certain WBC called myeloid cells in which the body overproduces these cells abnormally. The medicine is also used in adults to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL). Do not take inflitza capsule if you are allergic to midostaurin or any other ingredients of this medicine. Inform your healthcare professional if you have any symptoms of an infection, heart disorder, lung problems, or problems with breathing. If you experience any of these symptoms, such as fever, sore throat, mouth ulcers, cough with or without mucous, chest pain, difficulty breathing, or swelling in the body parts after taking the medicine, immediately report it to your doctor. This medicine is not recommended for children and adolescents below 18 years of age. Inform your physician if you are pregnant, breastfeeding, or planning for pregnancy before initiating the therapy. Inflitza 25mg capsule may reduce fertility in men and women; discuss this with your doctor before starting the therapy. This medicine's most common side effects are fever with reduced blood cell counts, nausea, vomiting, headache, musculoskeletal pain, increased blood glucose levels, and respiratory tract infection.
Active Pharmaceutical Ingredient
Uses
• Acute myeloid leukemia (AML)
• Aggressive systemic mastocytosis (ASM)
• Systemic mastocytosis with associated hematological neoplasm (SM-AHN)
• Mast cell leukemia (MCL)
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Inflitza 25mg Capsule side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Inflitza 25mg side effects are
Most Common Side Effects
• Swelling in the lower limbs
• Skin rash
• Increased blood sugar levels
• Abdominal pain
• Constipation, diarrhea
• Nausea, vomiting
• Musculoskeletal pain
• Headache
• Bleeding from nose
• Upper respiratory infection
• Tiredness
• Fever
Common Side Effects
• Heart failure
• GI bleeding
• Fever with decreased blood cell counts
• Hypersensitivity reactions
• Kidney problems
• Pneumonia
• Blood infection
How To Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the inflitza 25mg capsule as prescribed by your doctor. Do not open, break, crush, or chew the capsules. Swallow the capsule whole with a glass of water. Take the capsules with food at the same time each day.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking inflitza 25mg capsule because the medicine passes into the breast milk in small amounts and may harm the baby.
• Alcohol: It is unsafe to consume alcohol when taking inflitza 25mg capsule because it may cause alcohol-related problems, epilepsy, or liver problems.
• Liver: Inflitza 25mg capsule should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether inflitza 25mg capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving vehicles or operating machinery after taking inflitza 25mg capsule is unsafe as you may develop dizziness and vertigo.
• Pregnancy: Inflitza 25mg capsule is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using effective contraception during the treatment and for at least 4 months after your last dose is necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.